Tag: Chronic

World's First PB2-Targeted Treatment Developed Under Zhong Nanshan's Leadership China has approved Onladivir, a first-in-class influenza treatment targeting the PB2 ...

A recent study published in the Journal of the European Academy of Dermatology and Venereology has found that individuals with ...

The Revolutionizing Atopic Dermatitis (RAD) 2025 meeting in Nashville, Tennessee, featured a poster presentation on the JADE REAL study, which ...

Recently, a study published in JAMA Ophthalmology pointed out that GLP-1 drugs (such as Ozempic and Wegovy) may be associated ...

Allergic conditions ranging from dermatitis to life-threatening anaphylaxis represent some of medicine's most common yet misunderstood challenges. These disorders stem ...

At the recent FCPANP25 conference, a special presentation on chronic hand eczema (CHE) became the center of attention. Two authoritative ...

Foot eczema is a chronic inflammatory skin condition that can be triggered by a variety of factors. Understanding these causes ...

Grade III-A Facility Combines Traditional Medicine with Modern Management ANSHAN, China - Anshan Traditional Chinese Medicine Hospital, established in 1990 ...

Chronic hand eczema (CHE) is a multifactorial skin condition that significantly impacts patients' quality of life, with substantial physical, psychological, ...

Chronic hand eczema (CHE) is a multifactorial skin condition that poses significant diagnostic challenges and severely impacts patients' quality of ...